Plasma p-tau217: from ‘new kid’ to most promising candidate for Alzheimer’s disease blood test
Charlotte E. Teunissen, Elisabeth H. Thijssen, Inge M.W. Verberk
Abstract
This scientific commentary refers to ‘Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease’, by Mattsson-Carlgren et al. (doi:10.1093/brain/awaa286).
Topics & Concepts
Alzheimer's diseaseDiseaseMedicinePsychologyNeuroscienceInternal medicineAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPharmacological Effects and Toxicity Studies